1. Most Discussed
  2. Gainers & Losers
SPL $1.22

2015 a Watershed Year for Starpharma, Says Bell Potter

  1. nikki

    159 Posts.
    DJ 2015 a Watershed Year for Starpharma, Says Bell Potter -- Market Talk
    [5:48 ET] Starpharma's (SPL.AU) recent A$21.5 million capital raising prompts Bell
    Potter to cut its price target by 10% to A$0.99/share, but the broker remains upbeat
    about the stock's prospects. Starpharma's cash balance stands at around A$39.3
    million, which would allow it comfortably to progress its pipeline of advanced drugs, the
    broker says. Interest is building in Starpharma's dendrimer-docetaxel drug in
    development, following positive preliminary data from trials on animals and a phase-one
    trial in humans. Bell Potter, which retains a buy call, says the company is better
    equipped to engage in meaningful licensing discussions with both existing and potential
    partners on its various drug-delivery program. Separately, Bell Potter thinks
    Starpharma's VivaGel Coated Condom will start generating revenue from the second
    half of 2015, rising to US$20 million in FY21 as the product is launched in new markets
    and marketing encourages more people to try it. SPL last traded at A$0.475.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.